Suppr超能文献

细胞外基质衍生损伤相关分子模式(DAMP):在系统性硬化症和纤维化中的意义。

Extracellular Matrix-Derived Damage-Associated Molecular Patterns (DAMP): Implications in Systemic Sclerosis and Fibrosis.

机构信息

Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Michigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

J Invest Dermatol. 2023 Oct;143(10):1877-1885. doi: 10.1016/j.jid.2023.04.030. Epub 2023 Jul 14.

Abstract

Damage-associated molecular patterns (DAMPs) are intracellular molecules released under cellular stress or recurring tissue injury, which serve as endogenous ligands for toll-like receptors (TLRs). Such DAMPs are either actively secreted by immune cells or passively released into the extracellular environment from damaged cells or generated as alternatively spliced mRNA variants of extracellular matrix (ECM) glycoproteins. When recognized by pattern recognition receptors (PRRs) such as TLRs, DAMPs trigger innate immune responses. Currently, the best-characterized PRRs include, in addition to TLRs, nucleotide-binding oligomerization domain-like receptors, RIG-I-like RNA helicases, C-type lectin receptors, and many more. Systemic sclerosis (SSc) is a chronic autoimmune condition characterized by inflammation and progressive fibrosis in multiple organs. Using an unbiased survey for SSc-associated DAMPs, we have identified the ECM glycoproteins fibronectin-containing extra domain A and tenascin C as the most highly upregulated in SSc skin and lung biopsies. These DAMPs activate TLR4 on resident stromal cells to elicit profibrotic responses and sustained myofibroblasts activation resulting in progressive fibrosis. This review summarizes the current understanding of the complex functional roles of DAMPs in the progression and failure of resolution of fibrosis in general, with a particular focus on SSc, and considers viable therapeutic approaches targeting DAMPs.

摘要

损伤相关分子模式(DAMPs)是细胞应激或反复组织损伤下释放的细胞内分子,它们作为 Toll 样受体(TLRs)的内源性配体。这些 DAMPs 要么由免疫细胞主动分泌,要么从受损细胞被动释放到细胞外环境中,要么作为细胞外基质(ECM)糖蛋白的可变剪接 mRNA 变体产生。当被模式识别受体(PRRs)如 TLRs 识别时,DAMPs 会引发先天免疫反应。目前,除 TLRs 外,最好表征的 PRRs 还包括核苷酸结合寡聚化结构域样受体、RIG-I 样 RNA 解旋酶、C 型凝集素受体等。系统性硬化症(SSc)是一种慢性自身免疫性疾病,其特征是多个器官的炎症和进行性纤维化。通过对 SSc 相关 DAMPs 的无偏调查,我们已经确定 ECM 糖蛋白纤维连接蛋白包含的外显子 A 和 tenascin C 是 SSc 皮肤和肺活检中上调最明显的。这些 DAMPs 激活驻留基质细胞上的 TLR4,引发促纤维化反应,并持续激活肌成纤维细胞,导致进行性纤维化。本综述总结了 DAMPs 在纤维化进展和消退失败中的复杂功能作用的最新认识,特别是针对 SSc,并考虑了针对 DAMPs 的可行治疗方法。

相似文献

1
Extracellular Matrix-Derived Damage-Associated Molecular Patterns (DAMP): Implications in Systemic Sclerosis and Fibrosis.
J Invest Dermatol. 2023 Oct;143(10):1877-1885. doi: 10.1016/j.jid.2023.04.030. Epub 2023 Jul 14.
2
Tenascin-C in fibrosis in multiple organs: Translational implications.
Semin Cell Dev Biol. 2022 Aug;128:130-136. doi: 10.1016/j.semcdb.2022.03.019. Epub 2022 Apr 8.
3
Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy.
Immunol Lett. 2018 Mar;195:9-17. doi: 10.1016/j.imlet.2017.09.011. Epub 2017 Sep 28.
4
Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma.
Adv Wound Care (New Rochelle). 2017 Oct 1;6(10):356-369. doi: 10.1089/wound.2017.0732.
6
Pattern-recognition receptors in endometriosis: A narrative review.
Front Immunol. 2023 Mar 23;14:1161606. doi: 10.3389/fimmu.2023.1161606. eCollection 2023.
7
Innate immunity in systemic sclerosis pathogenesis.
Clin Sci (Lond). 2014 Mar;126(5):329-37. doi: 10.1042/CS20130367.
8
Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis.
JCI Insight. 2022 Nov 8;7(21):e160684. doi: 10.1172/jci.insight.160684.
9
Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.
Curr Rheumatol Rep. 2015 Jan;17(1):474. doi: 10.1007/s11926-014-0474-z.
10
Role of innate immune system in systemic sclerosis.
Semin Immunopathol. 2015 Sep;37(5):511-7. doi: 10.1007/s00281-015-0503-7. Epub 2015 Jul 10.

引用本文的文献

1
Fibroblast-Myofibroblast Transition in Osteoarthritis Progression: Current Insights.
Int J Mol Sci. 2025 Aug 15;26(16):7881. doi: 10.3390/ijms26167881.
2
Neutrophils and NETs in Pathophysiology and Treatment of Inflammatory Bowel Disease.
Int J Mol Sci. 2025 Jul 23;26(15):7098. doi: 10.3390/ijms26157098.
4
Damage-associated molecular patterns (DAMPs) in vascular diseases.
J Biol Chem. 2025 May 15;301(6):110241. doi: 10.1016/j.jbc.2025.110241.
6
Aging, ROS, and cellular senescence: a trilogy in the progression of liver fibrosis.
Biogerontology. 2024 Nov 15;26(1):10. doi: 10.1007/s10522-024-10153-3.
7
Multi-scalar data integration decoding risk genes for chronic kidney disease.
BMC Nephrol. 2024 Oct 18;25(1):364. doi: 10.1186/s12882-024-03798-2.
8
Inhibiting triggering receptor expressed on myeloid cells 1 signaling to ameliorate skin fibrosis.
JCI Insight. 2024 Dec 6;9(23):e176319. doi: 10.1172/jci.insight.176319.
9
Pathogenesis of Inflammation in Skin Disease: From Molecular Mechanisms to Pathology.
Int J Mol Sci. 2024 Sep 21;25(18):10152. doi: 10.3390/ijms251810152.
10
The emerging role of neutrophil extracellular traps in ulcerative colitis.
Front Immunol. 2024 Aug 7;15:1425251. doi: 10.3389/fimmu.2024.1425251. eCollection 2024.

本文引用的文献

1
Matrix protein Tenascin-C promotes kidney fibrosis via STAT3 activation in response to tubular injury.
Cell Death Dis. 2022 Dec 15;13(12):1044. doi: 10.1038/s41419-022-05496-z.
2
Advances on the roles of tenascin-C in cancer.
J Cell Sci. 2022 Sep 15;135(18). doi: 10.1242/jcs.260244. Epub 2022 Sep 14.
6
Tenascin-C in fibrosis in multiple organs: Translational implications.
Semin Cell Dev Biol. 2022 Aug;128:130-136. doi: 10.1016/j.semcdb.2022.03.019. Epub 2022 Apr 8.
7
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis.
Clin Exp Rheumatol. 2022 Oct;40(10):1921-1925. doi: 10.55563/clinexprheumatol/mpgq0y. Epub 2021 Oct 19.
8
Stimulation of toll-like receptor pathways by burn eschar tissue as a possible mechanism for hypertrophic scarring.
Wound Repair Regen. 2021 Sep;29(5):810-819. doi: 10.1111/wrr.12940. Epub 2021 May 27.
9
Splicing factor SRSF6 mediates pleural fibrosis.
JCI Insight. 2021 May 24;6(10):146197. doi: 10.1172/jci.insight.146197.
10
Citrullinated vimentin mediates development and progression of lung fibrosis.
Sci Transl Med. 2021 Mar 17;13(585). doi: 10.1126/scitranslmed.aba2927.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验